Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000596432 | SCV000708030 | uncertain significance | not provided | 2017-05-01 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000596432 | SCV002541571 | uncertain significance | not provided | 2021-08-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002532605 | SCV002996842 | benign | Spastic paraplegia | 2024-09-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002532604 | SCV003529373 | likely benign | Inborn genetic diseases | 2022-06-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |